Buradasınız

EFFECT OF POYMERIC RATIOS OF HPMC K15, SODIUM ALGINATE AND XANTHAN GUM ON THE SWELLING INDEX OF NIMODIPINE SUSTAINED RELEASE AND IT’S SIGNIFICANCE

Journal Name:

Publication Year:

Author NameUniversity of Author
Abstract (2. Language): 
The present study focuses on studying the effect of swelling capacity of Nimodipine Sustained release tablets such that for all formulations it increases as increase the concentration of gum in each formulation. During the study it was observed that drug release decreases with increasing concentration of gum and swelling index. The reason attributed to this fact is formation of thick gel layer by matrices around tablets that delays diffusion and release drug. It was observed that swelling index of matrix tablets containing only one natural polymer was less this may attributed to the lower water uptake and less hydrophilicity. For all the ten formulations there was no occurrence of initial burst release, but the release was constant in a controlled manner for a prolong period of time up to 12hrs. The initial release of drug from these matrices occurs by the drug dissolution in the water penetrated into the matrix. The overall drug release from these matrices is governed by hydration, gel layer formation and drug diffusion into the gel layer and to the dissolution media. Polymer erosion also plays a major role in releasing drug from these matrices. . Swelling index of tablets prepared from NMP5 resulted as better swelling behavior with respect to concentration.
552
559

REFERENCES

References: 

1. C. S. L. Chalo, J. R. Robinson, V. H. L. Lee. Sustained
Release Drug Delivery Systems, Remington’s
Pharmaceutical Sciences, 17th ed. Mack, 1995.
2. D. M. Brahmankar S. B. Jaiswal. Biopharmaceutics
and Pharmacokinetics a Treatise, 1st ed New Delhi,
Vallabh Prakashan, 1995.
3. Y. W. Chein. Novel Drug Delivery Systems, 2 ed. New
York, Marcel Dekker, 1992.
4. N. K. Jain NK. Controlled and Novel Drug Delivery,
1st ed New Delhi, CBS Publishers and Distributors,
1997.
5. S. P. Vyas, R. K. Khar. Text Book of Controlled Drug
Delivery, 1st ed. Vallabh Prakashan, 2002.
6. J. R. Robinson, V. H. L. Lee. Controlled Drug Delivery:
Fundamentals and Applications, 2nd ed. New York,
Marcel Dekker, 1978.
7. J. K. Lalla. Introduction to Controlled Release and
Oral Controlled Drug Delivery System, The Eastern
Pharmacist 45: 25-28 (1991).
8. G. M. Jantzen, J. R. Robinson, G. S. Banker, C. T.
Rhode. Sustained and Controlled Release Drug
Delivery, 3rd ed. Marcel Dekker, 1996.
9. K. Takada, K. H. Yoshi. Oral drug delivery–
Traditional, Encyclopedia of Controlled Release
Drug Delivery, John Wiley and Sons Inc; 1999.
10. P. Colombo. Swelling controlled release in hydro gel
matrices for oral route, Adv Drug Del Review 37-
57 (1993).
11. C. S. Satish, K. P. Satish, H. G. Shivkumar. Hydrogel as
Controlled Drug Delivery System: synthesis, cross
linking, water and drug transport mechanism,
Indian J Pharm Sci 68(2): 133-40 (2006).
12. A. Harrower. Gliclazide modified release: from once
daily administration to 24- hour blood glucose
control, W. B. Saunders Company 2000.
13. H. Abdelkader, O. Y. Abdalla, H. Salem. Formulation
of controlled-release baclofen matrix tablets:
Influence of some hydrophilic polymers on the
release rate and in vitro evaluation, AAPS Pharm Sci
Tech 8: 4 (2007).
14. K. D. Tripathi. Essentials of medical pharmacology,
4th edition, updated reprint 2001 pp. 157.
15. R. C. Rowe, P. J. Sheskey, M. E. Quinn. Handbook of
Pharmaceutical excipients, 2009.

Thank you for copying data from http://www.arastirmax.com